Talacen

Pentazocine The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)

Molecular Formula: C₁₉H₂₈ClNO

InChI: InChI=1/C19H27NO.ClH/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19;/h5-7,12,14,18,21H,8-11H2,1-4H3;1H/t14-,18+,19+;/m0./s1

InChIKey: InChIKey=OQGYMIIFOSJQSF-DTOXXUQYBX
SMILES: CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O.Cl

Names:
    D02227
    Pentazocine hydrochloride (JAN/USP)
    Pentazocine hydrochloride
    Sosegon (TN)
    Sosegon
    Talacen (TN)
    Talacen
    64024-15-3

Registries:
    PubChem CID 441277
    PubChem ID 7849286